Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
lswicker@well.ox.ac.uk

Linda Wicker

Recent publications

Therapeutically expanded human regulatory T-cells are super-suppressive due to HIF1A induced expression of CD73.
Journal article

Jarvis LB. et al, (2021), Commun Biol, 4
Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.
Journal article

Robertson CC. et al, (2021), Nature genetics
Single-cell multi-omics analysis reveals IFN-driven alterations in T lymphocytes and natural killer cells in systemic lupus erythematosus
Journal article

Trzupek D. et al, (2021), Wellcome Open Research, 6, 149 - 149
Therapeutically expanded human regulatory T-cells are super- suppressive due to HIF1A induced expression of CD73.
Jarvis L. et al, (2020)
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial
Journal article

Marcovecchio ML. et al, (2020), Wellcome Open Research, 5, 49 - 49

More publications